Compound information
- Natural Products
- ZC390611
- Molecular Formula
- C13H16N2O
- Molecular Weight
- 216.126263132 g/mol
- Structure
-
- IUPAC Name
- N-[(3R)-1-phenylpyrrolidin-3-yl]prop-2-enamide
- InChI
- InChI=1S/C13H16N2O/c1-2-13(16)14-11-8-9-15(10-11)12-6-4-3-5-7-12/h2-7,11H,1,8-10H2,(H,14,16)/t11-/m1/s1
- InChI Key
- PGJQDJCCVFTOHK-LLVKDONJSA-N
- SMILES
- C=CC(=O)N[C@@H]1CCN(c2ccccc2)C1
- Source
- ZINC000848979209
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 16 | Ring Count | 2 |
Heteroatom Count | 3 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 32.34 Å2 | LogP | 2.216 |
LogS | -2.472 | LogD | 1.685 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.023 | Pgp substrate | 0.978 |
HIA | 0.962 | F20 % | 0.992 |
F30 % | 0.636 | Caco-2 | -4.843 |
MDCK | -4.723 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.891 | PPB | 63.797 |
VD | 1.239 | Fu | 0.393 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.461 | CYP1A2 substrate | 0.523 |
CYP2A6 substrate | 0.691 | CYP2B6 substrate | 0.589 |
CYP2C19 inhibitor | 0.147 | CYP2C19 substrate | 0.64 |
CYP2C8 substrate | 0.494 | CYP2C9 inhibitor | 0.006 |
CYP2C9 substrate | 0.997 | CYP2D6 inhibitor | 0.006 |
CYP2D6 substrate | 0.968 | CYP2E1 substrate | 0.883 |
CYP3A4 inhibitor | 0.012 | CYP3A4 substrate | 0.925 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.574 | CL | 6.475 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.08 | Hepatotoxicity | 0.962 |
Mutagenicity | 0.008 | Rat Oral Acute Toxicity | 0.136 |
FDAMDD | 0.45 | Skin Sensitization | 0.999 |
Carcinogenicity | 0.093 | Eye Corrosion | 0.993 |
Eye Irritation | 0.964 | Respiratory Toxicity | 0.616 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.099 | IGC50 | 2.702 |
LC50FM | 2.971 | LC50DM | 3.028 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.208 | NR-AR-LBD | 0.238 |
NR-AhR | 0.006 | NR-Aromatase | 0.026 |
NR-ER | 0.32 | NR-ER-LBD | 0.322 |
NR-PPAR-gamma | 0.346 | SR-ARE | 0.775 |
SR-ATAD5 | 0.404 | SR-HSE | 0.133 |
SR-MMP | 0.019 | SR-p53 | 0.042 |
Similar covalent drugs
No similar covalent drugs found for this compound.